<DOC>
	<DOCNO>NCT01895153</DOCNO>
	<brief_summary>The efficacy pentosan polysulfate sodium , hydrodistension combination therapy patient bladder pain syndrome .</brief_summary>
	<brief_title>Efficacy Study Pentosan Polysulfate Sodium , Hydrodistension Combination Therapy Bladder Pain Syndrome</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Somatoform Disorders</mesh_term>
	<mesh_term>Cystitis , Interstitial</mesh_term>
	<mesh_term>Pentosan Sulfuric Polyester</mesh_term>
	<criteria>1. men woman 18 year old symptom 6 month . 2 . 4 pain visual analogue score 3 . 12 O'LearySant Intersttial Cystitis questionnaire ( ICQ ) symptom problem score pain score nocturia score 2 . 1. history hydrodistention , augumentation cystoplasty due IC/BPS 2. pentosan polysulfate sodium ( Elmiron ) history 1 month within 6 month . 3 . Women childbearing potential pregnant nursing 4. mean void volume lesser 40ml 400ml . 5. hematuria exceeds 1+ urinary dipstick ( dipstick ) examination . 6. urinary tract infection runin period . 7. genitourinary tuberculosis bladder , urethral prostate cancer 8. recurrent urinary tract infection 9. history hystrectomy , midurethral sling , pelvic organ prolapse repair , vaginal delivery Cesarean section , prostate opreation treatment etc within 6months . 10. neurologic disease history cerebral infaction , multiple sclerosis parkinsonism etc .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2014</verification_date>
	<keyword>bladder pain syndrome</keyword>
	<keyword>pentosan polysulfate</keyword>
	<keyword>hydrodistension</keyword>
</DOC>